FX006 32 mg
FX006-2014-007
Phase 2 small_molecule terminated
Quick answer
FX006 32 mg for Post-traumatic Osteoarthritis of the Knee is a Phase 2 program (small_molecule) at Pacira BioSciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pacira BioSciences
- Indication
- Post-traumatic Osteoarthritis of the Knee
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated